BRCA2 mutations in hereditary breast and ovarian cancer in France

被引：0
|
作者：
SerovaSinilnikova, OM
Boutrand, L
StoppaLyonnet, D
BressacdePaillerets, B
Dubois, V
Lasset, C
Janin, N
Bignon, YJ
Longy, M
Maugard, C
Lidereau, R
Leroux, D
Frebourg, T
Mazoyer, S
Lenoir, GM
机构：
[1] CTR INT RECH CANC,F-69372 LYON 08,FRANCE
[2] CNRS,GENET LAB,UMR5641,LYON,FRANCE
[3] HOP EDOUARD HERRIOT,LYON,FRANCE
[4] CTR LEON BERARD,F-69373 LYON,FRANCE
[5] INST CURIE,PARIS,FRANCE
[6] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
[7] CTR JEAN PERRIN,CLERMONT FERRAN,FRANCE
[8] CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE
[9] INST BERGONIE,BORDEAUX,FRANCE
[10] CTR RENE HUGUENIN,ST CLOUD,FRANCE
[11] CHU GRENOBLE,F-38043 GRENOBLE,FRANCE
[12] CHR ROUEN,HOP CHARLES NICOLLE,ROUEN,FRANCE
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 60卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：1236 / 1239
页数：4
相关论文
共 50 条
  • [31] BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer
    Schubert, EL
    Mefford, HC
    Dann, JL
    Argonza, RH
    Hull, J
    King, MC
    GENETIC TESTING, 1997, 1 (01): : 41 - 46
  • [32] Clinical relevance of ten BRCA1 and three BRCA2 intronic germline mutations in families with hereditary breast and/or ovarian cancer
    Wappenschmidt, B.
    Kohler, J.
    Bosse, K.
    Versmold, B.
    Schmutzler, R. K.
    ONKOLOGIE, 2008, 31 : 29 - 29
  • [33] Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
    Rashid, Muhammad U.
    Zaidi, Anbreen
    Torres, Diana
    Sultan, Faisal
    Benner, Axel
    Naqvi, Bilal
    Shakoori, Abdul R.
    Seidel-Renkert, Antje
    Farooq, Humirah
    Narod, Steven
    Amin, Asim
    Hamann, Ute
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2832 - 2839
  • [34] Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient
    Randall, TC
    Bell, KA
    Rebane, BA
    Rubin, SC
    Boyd, J
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 432 - 434
  • [35] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Suman J. Ramus
    Lori S. Friedman
    Simon A. Gayther
    Bruce A.J. Ponder
    Lynda G. Bobrow
    Marco van der Looji
    Janos Papp
    Edith Olah
    Nature Genetics, 1997, 15 : 14 - 15
  • [36] Germline Mutations of BRCA1 and BRCA2 in Korean Breast and/or Ovarian Cancer Families
    Kang, Hio Chung
    Kim, Il-Jin
    Park, Jae-Hyun
    Kwon, Hyuk-Jun
    Won, Yong-Jin
    Heo, Seung Chul
    Lee, Sang-Yon
    Kim, Kyung-Hee
    Shin, Yong
    Noh, Dong Young
    Yang, Dae-Hyun
    Choe, Kuk Jin
    Lee, Bong Hwa
    Kang, Soon Beom
    Park, Jae-Gahb
    HUMAN MUTATION, 2002, 20 (03) : 235
  • [37] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    SCIENCE, 2003, 302 (5645) : 643 - 646
  • [38] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Ramus, SJ
    Friedman, LS
    Gayther, SA
    Ponder, BAJ
    Bobrow, LG
    vanderLooji, M
    Papp, J
    Olah, E
    NATURE GENETICS, 1997, 15 (01) : 14 - 15
  • [39] BRCA2 Germline Mutations in Cypriot Patients With Familial Breast/Ovarian Cancer
    Hadjisavvas, Andreas
    Charalambous, Elpida
    Adamou, Adamos
    Christodoulou, Christina G.
    Kyriacou, Kyriacos
    HUMAN MUTATION, 2003, 21 (02)
  • [40] BRCA2 mutations in male breast cancer
    Young, IE
    Kurian, KM
    Mackenzie, MAF
    Back, JMV
    Annink, C
    Kunkler, IH
    Steel, CM
    JOURNAL OF PATHOLOGY, 2000, 192 : 20A - 20A
12345